🇺🇸 FDA
Patent

US 6162787

Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions

expired A61KA61K38/39

Quick answer

US patent 6162787 (Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions) held by Immudyne, Inc. expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Immudyne, Inc.
Grant date
Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K38/39